PTX3, COLEC12 and PDGFRA proved to differentiate anaplastic thyroid carcinomas from other subtype while GPR110 seems suitable to become a biomarker for papillary thyroid carcinomas. This evidence concerns the gene PDGFRA and thyroid gland papillary carcinoma.